S. Vasikaran

S. Vasikaran, J. Grasko, R. Herrmann, 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Error rates in Australian chemical pathology laboratories.

S. Vasikaran, P. Sheehan, 1996, The Medical journal of Australia.

Review of a pilot quality-assessment program for interpretative comments

S. Vasikaran, J. Gill, K. Sikaris, 2002, Annals of clinical biochemistry.

Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults.

P. Glendenning, S. Vasikaran, S. A. Chubb, 2018, Clinica chimica acta; international journal of clinical chemistry.

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

P. Glendenning, C. Inderjeeth, S. Vasikaran, 2009, Bone.

Alendronate in the treatment of Paget's disease of bone.

J. Kanis, E. McCloskey, S. Vasikaran, 1997, Bone.

The Role of PINP in Diagnosis and Management of Metabolic Bone Disease.

C. Inderjeeth, S. Vasikaran, M. Gillett, 2021, The Clinical biochemist. Reviews.

25-Hydroxyvitamin D C3-epimer is universally present in neonatal Western Australian samples but is unlikely to contribute to diagnostic misclassification

P. Glendenning, S. Vasikaran, B. Cooke, 2016, Annals of clinical biochemistry.

Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays

P. Glendenning, S. Vasikaran, W. Fraser, 2006, Annals of clinical biochemistry.

Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases

P. Glendenning, S. Vasikaran, W. Fraser, 2003, Annals of clinical biochemistry.

Harmonization of commercial assays for PINP; the way forward

S. Silverman, J. Kanis, R. Eastell, 2020, Osteoporosis International.

Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood.

S. Silverman, J. Kanis, R. Eastell, 2020, Clinica chimica acta; international journal of clinical chemistry.

Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis

J. Kanis, E. McCloskey, S. Vasikaran, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The role of biochemical markers of bone turnover in osteoporosis

P. Glendenning, S. Vasikaran, H. Morris, 2006, Osteoporosis International.

The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis

S. Vasikaran, S. A. Paul Chubb, S. A. Paul Chubb, 2016, Endocrine.

Homocysteine and vitamin status in older people in Perth

S. Vasikaran, K. Jamrozik, P. Norman, 2004, Medical Journal of Australia.

Parathyroid hormone is more stable in EDTA plasma than in serum.

P. Glendenning, S. Vasikaran, A. Musk, 2002, Clinical chemistry.

A conversation between two viruses: SARS-CoV and SARS-CoV-2 – based on a true story

S. Vasikaran, B. Vásárhelyi, Z. Tóth, 2020 .

Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis

S. Vasikaran, E. Cavalier, M. Miura, 2021, Calcified Tissue International.

contemporary assay on the Abbott ARCHITECT analyser Outliers affecting cardiac troponin I measurement : comparison of a new high sensitivity assay with a

S. Vasikaran, R. Lambert, P. Sheehan, 2014 .

Decision limit for troponin I and assay performance

S. Vasikaran, P. Sheehan, J. Blennerhassett, 2002, Annals of clinical biochemistry.

C‐reactive protein: a new cardiovascular risk factor?

G. Watts, S. Vasikaran, J. Burnett, 2000, The Medical journal of Australia.

Index of Individuality and Utility of Population Based Reference Range

S. Vasikaran, 1993, Annals of clinical biochemistry.

Outliers affecting cardiac troponin I measurement: comparison of a new high sensitivity assay with a contemporary assay on the Abbott ARCHITECT analyser

S. Vasikaran, R. Lambert, P. Sheehan, 2014, Annals of clinical biochemistry.

Butyrylcholinesterase K variant and Alzheimer’s disease

S. Vasikaran, P. Panegyres, C. Mamotte, 1999, Journal of Neurology.

A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture

C. Cooper, J. Kanis, E. McCloskey, 2014, Calcified Tissue International.

An audit of oral glucose tolerance tests at a large teaching hospital: indications, outcomes and confounding factors

S. Vasikaran, D. Siriwardhana, J. Ryan, 2009, Annals of clinical biochemistry.

Trends in Laboratory Testing Practice for Diabetes Mellitus

S. Vasikaran, M. Banerjee, 2020, EJIFCC.

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir

M. John, I. James, S. Mallal, 2001, AIDS.

Is vitamin D testing at a tertiary referral hospital consistent with guideline recommendations?

P. Glendenning, S. Vasikaran, G. Chew, 2015, Pathology.

Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations

S. Vasikaran, H. Vesper, A. Heijboer, 2021, Nutrients.

The path to the standardization of PTH: Is this a realistic possibility? A position paper of the IFCC C-BM.

S. Vasikaran, A. Heijboer, C. Ulmer, 2021, Clinica chimica acta; international journal of clinical chemistry.

Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome

S. Vasikaran, D. Fatovich, J. Grasko, 2010, Emergency Medicine Journal.

Interpretative commenting.

S. Vasikaran, 2008, The Clinical biochemist. Reviews.

Assessment of bone turnover in osteoporosis: harmonization of the total testing process

S. Vasikaran, 2018, Clinical chemistry and laboratory medicine.

Anatomy and history of an external quality assessment program for interpretative comments in clinical biochemistry.

S. Vasikaran, 2015, Clinical biochemistry.

A discussion of cases in the 2001 RCPA‐AQAP Chemical Pathology Case Report Comments Program

J. Beilby, S. Vasikaran, J. Gill, 2003, Pathology.

The assessment of interpretation in clinical biochemistry: a personal view

S. Vasikaran, G. Challand, 2007, Annals of clinical biochemistry.

Current use of bone turnover markers in the management of osteoporosis.

Jacques P. Brown, S. Vasikaran, A. Don-Wauchope, 2022, Clinical biochemistry.

Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2.

C. Christiansen, P. Glendenning, S. Vasikaran, 2009, Clinica chimica acta; international journal of clinical chemistry.

Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis.

G. Watts, S. Vasikaran, K. Croft, 2001, Clinica chimica acta; international journal of clinical chemistry.

Standardising biochemical assessment of bone turnover in osteoporosis.

C. Cooper, J. Kanis, S. Vasikaran, 2011, Clinical biochemistry.

Prospective audit of the anti-thrombotic management of atrial aibrillation in the elderly IV / .

C. Anderson, G. Hankey, J. McNeil, 2004 .

Faecal calprotectin

S. Vasikaran, M. Gillett, S. Chubb, 2018, Radiopaedia.org.

B-vitamins reduce plasma levels of beta amyloid

R. Martins, S. Vasikaran, K. Jamrozik, 2008, Neurobiology of Aging.

Bone turnover marker monitoring in osteoporosis treatment response.

S. Vasikaran, T. P. Loh, Rui Zhen Tan, 2020, European journal of endocrinology.

High‐sensitivity troponin in marathon runners

S. Vasikaran, D. Fatovich, Michael R Phillips, 2013, The Medical journal of Australia.

An audit of management of patients with borderline increased plasma-free metanephrines

S. Vasikaran, S. S. Anas, 2010, Annals of clinical biochemistry.

Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays--an update from the Canadian society of clinical chemists (CSCC); the case for age related acute myocardial infarction (AMI) cut-offs.

S. Vasikaran, K. Sikaris, M. Botros, 2012, Clinical biochemistry.

Vitamin D status and redefining serum PTH reference range in the elderly.

P. Glendenning, S. Vasikaran, 2002, The Journal of clinical endocrinology and metabolism.

Vitamin D insufficiency and hyperparathyroidism in Perth blood donors

S. Vasikaran, L. Flicker, A. Musk, 2000, The Medical journal of Australia.

A G5569A HFE Gene Polymorphism that Interferes in DNA Tests for Genetic Haemochromatosis: Who Needs to Be Re-tested?

F. Christiansen, S. Vasikaran, C. Mamotte, 2000, Clinical Chemistry and Laboratory Medicine.

Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significance

P. Glendenning, S. Vasikaran, 2002, Internal medicine journal.

Improved technical success and radiation safety of adrenal vein sampling using rapid, semi-quantitative point-of-care cortisol measurement

P. Glendenning, S. Vasikaran, D. Ramsay, 2018, Annals of clinical biochemistry.

Therapeutic efficiency of tirofiban in acute coronary syndromes

S. Vasikaran, J. Burnett, W. McConnell, 2000, The Lancet.

Major method-specific differences in the measurement of intact parathyroid hormone: studies in patients with and without chronic renal failure

S. Vasikaran, D. Gutteridge, R. Retallack, 2004, Annals of clinical biochemistry.

The effects of intravenous alendronate in Paget's disease of bone

J. Kanis, E. McCloskey, S. Vasikaran, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Suboptimal management of subclinical hypothyroidism

S. Vasikaran, M. Gillett, C. Yeo, 2004, The Medical journal of Australia.

Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis.

S. Vasikaran, 2008, Critical reviews in clinical laboratory sciences.

Correlation of paired toxic plasma and saliva paracetamol concentrations following deliberate self-poisoning with paracetamol.

S. Vasikaran, D. Fatovich, S. Burrows, 2012, British journal of clinical pharmacology.

Correlation of paired plasma and saliva paracetamol levels following deliberate self-poisoning with paracetamol (The Salivary Paracetamol In Toxicology [SPIT] study)

S. Vasikaran, D. Fatovich, F. Daly, 2008, Clinical toxicology.

Bone turnover markers: Defining a therapeutic target.

S. Vasikaran, J. Golledge, L. Manning, 2017, Clinical biochemistry.

A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life

Leon Flicker, S. Vasikaran, P. Leedman, 2006, Neurobiology of Aging.

Secondary hypoadrenalism presenting with hypercalcaemia

S. Vasikaran, W. Braund, G. Tallis, 1994, Clinical endocrinology.

Clinical Utility and Measurement of Procalcitonin.

S. Vasikaran, I. Samsudin, 2017, The Clinical biochemist. Reviews.

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

C. Cooper, S. Silverman, O. Bruyère, 2011, Osteoporosis International.

Association Between Homocysteine, Depression, and Cognitive Function in Community‐Dwelling Older Women from Australia

S. Vasikaran, P. Leedman, N. Lautenschlager, 2004, Journal of the American Geriatrics Society.

Anomalies in a DNA test for haemochromatosis

F. Christiansen, S. Vasikaran, C. Mamotte, 1998 .

Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life

S. Vasikaran, P. Leedman, N. Lautenschlager, 2005, Neurobiology of Aging.

Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

C. Cooper, E. McCloskey, S. Vasikaran, 2011, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture

C. Cooper, J. Kanis, E. McCloskey, 2014, Calcified Tissue International.

Hypercalcemia Differential Diagnosis and Investigation

P. Glendenning, S. Vasikaran, B. Stuckey, 2002 .

A high pressure liquid chromatography method for separation of prolactin forms

S. Vasikaran, D. Bell, K. Hoad, 2012, Annals of clinical biochemistry.

Comparison of 8 methods for univariate statistical exclusion of pathological subpopulations for indirect reference intervals and biological variation studies.

S. Vasikaran, T. P. Loh, Rui Zhen Tan, 2022, Clinical biochemistry.

A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism

J. Kanis, R. Eastell, S. Vasikaran, 2019, Clinical chemistry and laboratory medicine.

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.

J. Kanis, E. McCloskey, K. Eyres, 1992, British journal of cancer.

The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma

P. Glendenning, S. Vasikaran, K. Hoad, 2018, Annals of clinical biochemistry.

Methylenetetrahydrofolate reductase gene and coronary artery disease.

S. Vasikaran, C. Mamotte, F. V. van Bockxmeer, 1997, Circulation.

Association of cardiovascular risk factors and disease with depression in later life.

G. Hankey, S. Vasikaran, K. Jamrozik, 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of Osteoporosis

S. Vasikaran, 2008 .

Assuring the quality of interpretative comments in clinical chemistry

S. Vasikaran, T. Badrick, E. Kilpatrick, 2016, Clinical chemistry and laboratory medicine.

Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosis.

S. Vasikaran, S. A. Chubb, Christine Mandelt, 2016, Clinical biochemistry.

Comparison of results from commercial assays for plasma CTX: The need for harmonization.

S. Vasikaran, S. Chubb, S. A. Chubb, 2015, Clinical biochemistry.

Paget's disease: Acquired resistance to one aminobisphosphonate with retained response to another

S. Vasikaran, R. Prince, R. Price, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Functional Reference Limits: Describing Physiological Relationships and Determination of Physiological Limits for Enhanced Interpretation of Laboratory Results

S. Vasikaran, T. P. Loh, Rui Zhen Tan, 2023, Annals of Laboratory Medicine.

Comparison of four indirect (data mining) approaches to derive within-subject biological variation

S. Vasikaran, T. P. Loh, Rui Zhen Tan, 2022, Clinical chemistry and laboratory medicine.

Intra-Individual Variation in Fasting Urinary Calcium- and Hydroxyproline-Creatinine Ratios Measured in Metabolic Bone Clinic Patients as Both Outpatients and Inpatients

J. Kanis, E. McCloskey, S. Vasikaran, 1994, Annals of clinical biochemistry.

Sustained response to intravenous alendronate in postmenopausal osteoporosis.

J. Kanis, E. McCloskey, S. Vasikaran, 1995, Bone.

Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study.

J. Beilby, S. Vasikaran, J. Golledge, 2015, The Journal of clinical endocrinology and metabolism.

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study

S. Vasikaran, 2009, Osteoporosis International.

High‐Sensitivity Cardiac Troponin I Improves Cardiovascular Risk Prediction in Older Men: HIMS (The Health in Men Study)

G. Hankey, S. Vasikaran, J. Golledge, 2019, Journal of the American Heart Association.

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate

K. Eyres, N. O'Rourke, S. Vasikaran, 1993, British Journal of Cancer.

Recommendations for bone marker standards in osteoporosis: what, why and where to now?

C. Cooper, J. Kanis, S. Vasikaran, 2011, Annals of clinical biochemistry.

Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.

S. Vasikaran, V. Burke, F. V. van Bockxmeer, 2002, Clinical science.

Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia.

S. Vasikaran, P. Leedman, N. Lautenschlager, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

High-sensitivity cardiac troponin assays for risk stratification and for the diagnosis of acute myocardial infarction

S. Vasikaran, K. Sikaris, S. Macdonald, 2012, Annals of clinical biochemistry.

The adrenal vein sampling outcomes study (AVOS): success rates following adrenalectomy for unilateral primary aldosteronism.

P. Glendenning, S. Vasikaran, Jun Yang, 2023, Pathology.

Measuring myocardial damage

S. Vasikaran, J. Burnett, R. Clugston, 2001, The Medical journal of Australia.

Serum type 1 collagen carboxvterminal crosslinked telopeptide (S-1CTP) in Paget's disease of bone and the effect of treatment with bisphosphonates

J. Kanis, E. McCloskey, K. Eyres, 1992 .

Reference intervals for plasma β-CTX and P1NP in children: a systematic review and pooled estimates.

S. Vasikaran, S. Chubb, MJ Gillett, 2023, Clinical Biochemistry.

The effect of alendronate on renal tubular reabsorption of phosphate.

J. Kanis, E. McCloskey, S. Vasikaran, 1994, Bone and Mineral.